Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) very commonly
experience difficulty in initiating and maintaining sleep. Studies have shown that daytime
sleepiness resulting from insufficient sleep can affect attention and learning. Therefore,
treating insomnia in children with ADHD may not only improve sleep, but it could potentially
improve ADHD symptoms as well.
The main purpose of this study is to examine the effects of atomoxetine on ADHD-related
insomnia. Atomoxetine (Strattera®) is a non-stimulant drug used to treat ADHD symptoms in
both children and adults, and there is evidence that it may also have a positive effect on
sleep in children with ADHD. During the study, participants will receive either atomoxetine
or placebo for a period of four weeks. We expect that the effects of atomoxetine on sleep
will differ from those of placebo, with atomoxetine having a greater effect on improving
sleep difficulties.